Systemic therapy for bladder cancer is costly and should be weighed against the clinical outcomes likely to be achieved.
Chemotherapy may be overused among young and middle-aged patients with colon cancer.
Positron emission tomography scans during induction chemotherapy for esophageal cancer helps assess patient response to treatment and adjust their therapy, which could lead to an improved complete response rate prior to surgery, says a new study.
Patients with mantle cell lymphoma may be able to forego chemotherapy in favor of induction treatment with a two-drug regimen,.
Childhood survivors of bone cancer and soft-tissue sarcoma face increased risk of hospitalization for years after initial diagnosis.
Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing chemotherapy, according to new research.
An anti-PD-1 therapy significantly improves overall survival compared with chemotherapy in previously treated patients with advanced bladder cancer, according to a study presented at the Society for Immunotherapy of Cancer 2016 meeting.